Antimalarial medications: Difference between revisions
ClaireLewis (talk | contribs) (Created page with "''Recommended therapy for malaria depends on species, regional resistance patterns, and disease severity. Many treatment regimens include a combination of agents'' Medications...") |
(add See Also section) |
||
| Line 17: | Line 17: | ||
*Dihydroartemisinin | *Dihydroartemisinin | ||
*Piperaquine | *Piperaquine | ||
==See Also== | |||
*[[Malaria]] | |||
*[[Malaria prophylaxis]] | |||
==References== | ==References== | ||
Latest revision as of 08:46, 22 March 2026
Recommended therapy for malaria depends on species, regional resistance patterns, and disease severity. Many treatment regimens include a combination of agents Medications listed in most recent CDC guidelines[1] include:
- Atovaquone-proguanil (Malarone)
- Artemether-lumefantrine
- Artesunate
- Quinine, Quinidine
- Chloroquine, Hydroxychloroquine
- Primaquine
- Artesunate (not currently licensed in the US)
- Clindamycin, doxycycline, tetracycline (used in combination with quinine/quinidine)
Other antimalarials:
- Pyrimethamine
- Dapsone
- Atovaquone
- Amodiaquine
- Dihydroartemisinin
- Piperaquine